COLQ variant associated with Devon Rex and Sphynx feline hereditary myopathy. by Gandolfi, Barbara et al.
UC Davis
UC Davis Previously Published Works
Title
COLQ variant associated with Devon Rex and Sphynx feline hereditary myopathy.
Permalink
https://escholarship.org/uc/item/1gq3v10s
Journal
Animal genetics, 46(6)
ISSN
0268-9146
Authors
Gandolfi, Barbara
Grahn, Robert A
Creighton, Erica K
et al.
Publication Date
2015-12-01
DOI
10.1111/age.12350
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
SHORT COMMUNICATION
COLQ variant associated with Devon Rex and Sphynx feline
hereditary myopathy
Barbara Gandolfi1, Robert A. Grahn2, Erica K. Creighton1, D. Colette Williams3, Peter J. Dickinson4,
Beverly K. Sturges4, Ling T. Guo4, G. Diane Shelton5, Peter A. J. Leegwater6, Maria Longeri7,
Richard Malik8 and Leslie A. Lyons1
1Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri – Columbia, Columbia, MO
65211, USA. 2Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California – Davis, Davis, CA 95616, USA. 3The
William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California – Davis, Davis, CA 95616,
USA. 4Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California – Davis, Davis, CA 95616,
USA. 5Department of Pathology, University of California – San Diego, La Jolla, CA 92093, USA. 6Department of Clinical Sciences of
Companion Animals, Faculty of Veterinary Medicine, Utrecht University, 3508 TD, Utrecht, The Netherlands. 7Dipartimento di Scienze
Veterinarie e Sanita Pubblica, University of Milan, Milan, Italy. 8Centre for Veterinary Education, University of Sydney, Sydney, NSW 2006,
Australia.
Summary Some Devon Rex and Sphynx cats have a variably progressive myopathy characterized by
appendicular and axial muscle weakness, megaesophagus, pharyngeal weakness and
fatigability with exercise. Muscle biopsies from affected cats demonstrated variable
pathological changes ranging from dystrophic features to minimal abnormalities. Affected
cats have exacerbation of weakness following anticholinesterase dosing, a clue that there is
an underlying congenital myasthenic syndrome (CMS). A genome-wide association study
and whole-genome sequencing suggested a causal variant for this entity was a c.1190G>A
variant causing a cysteine to tyrosine substitution (p.Cys397Tyr) within the C-terminal
domain of collagen-like tail subunit (single strand of homotrimer) of asymmetric acetyl-
cholinesterase (COLQ). Alpha-dystroglycan expression, which is associated with COLQ
anchorage at the motor end-plate, has been shown to be deficient in affected cats. Eighteen
affected cats were identified by genotyping, including cats from the original clinical
descriptions in 1993 and subsequent publications. Eight Devon Rex and one Sphynx not
associated with the study were identified as carriers, suggesting an allele frequency of ~2.0%
in Devon Rex. Over 350 tested cats from other breeds did not have the variant.
Characteristic clinical features and variant presence in all affected cats suggest a model for
COLQ CMS. The association between the COLQ variant and this CMS affords clinicians the
opportunity to confirm diagnosis via genetic testing and permits owners and breeders to
identify carriers in the population. Moreover, accurate diagnosis increases available
therapeutic options for affected cats based on an understanding of the pathophysiology and
experience from human CMS associated with COLQ variants.
Keywords collagen-like tail subunit of asymmetric acetylcholinesterase, congenital myas-
thenic syndrome, domestic cat, Felis catus silvestris
Neuromuscular disorders encompass a variety of diseases
that impair normal function of skeletal muscle. A subset
of neuromuscular disorders, the congenital myasthenic
syndromes (CMSs), represent a heterogeneous group of
heritable diseases caused by abnormal signal transmission
at the motor endplate (EP), a synaptic connection between
motor axon nerve terminals and skeletal muscle fibers (see
review: Engel et al. 2015). Most CMSs are autosomal
recessive conditions characterized by functional or struc-
tural abnormalities of proteins localized to the presynaptic,
synaptic or postsynaptic regions of the motor EP. At least 18
genes are associated with genetically distinct forms of CMS
(http://www.ncbi.nlm.nih.gov/omim/?term=congenital+
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myasthenic+syndromes), encoding proteins expressed at
the neuromuscular junction. Their defined molecular basis
in human patients supports targeted and efficient therapies
for disease management and improved prognosis (see
reviews: Ohno & Engel 2003; Mihaylova et al. 2008; Engel
et al. 2012; Hantai et al. 2013).
Variants in collagen-like tail subunit (single strand of
homotrimer) of asymmetric acetylcholinesterase (COLQ) result
in EP acetylcholinesterase (AchE) deficiency (EAD) and
account for 10–15% of human CMS (Abicht et al. 2012). A
diagnostic clue to an EAD is worsening of clinical weakness
with anticholinesterase drugs (Engel et al. 2015). Thus,
therapeutic options in humans include the adrenergic
agonists ephedrine and albuterol, although mechanisms of
action are not understood. Approximately 30 COLQ vari-
ants are currently associated with CMS (Ohno et al. 2000;
Engel et al. 2003b; Engel & Sine 2005; Mihaylova et al.
2008).
Several animal models for neuromuscular disorders exist
(Gaschen et al. 2004; Shelton & Engvall 2005). Genetically
defined recessive CMS models, orthologs of human diseases,
are limited: Old Danish Pointing Dogs have a CHAT
missense variant (OMIA 000685-9615) (Proschowsky et al.
2007) and Brahman cattle have a CHRNE deletion (OMIA
000685-9913) (Kraner et al. 2002), whereas Labrador
retrievers are the only companion animal species with a
naturally occurring COLQ variant causing a CMS (OMIA
001928-9615) (Rinz et al. 2014).
A congenital myopathy in cats with autosomal recessive
inheritance has been defined in Devon Rex and Sphynx
breeds (OMIA 001621-9685) (Lievesley & Gruffydd-Jones
1989; Robinson 1992; Malik et al. 1993). Affected cats
present with passive ventroflexion of the head and neck,
head bobbing, scapulae protrusion, megaesophagus, gener-
alized muscle weakness and fatigability (Malik et al. 1993)
(Video S1, Case 1 (Martin et al. 2008); Video S2, Case 1
(Shelton et al. 2007)). Muscle biopsies from affected cats
demonstrated variable pathological changes ranging from
dystrophic features (Malik et al. 1993) to minimal abnor-
malities (Martin et al. 2008). Weakness of an affected cat
was exacerbated by dosing with edrophonium, a clue that
the problem might be a CMS. Crystalline inclusions were
reported in a single cat (Shelton et al. 2007). In a Sphynx
and Devon Rex with identical clinical presentations,
reduced expression of a-dystroglycan was noted, whereas
b-dystroglycan, sarcoglycans, laminin a2 and dystrophin
were expressed at normal levels (Martin et al. 2008).
To genetically localize the Devon Rex/Sphynx myopathy,
a case–control genome-wide association study was con-
ducted. Seven affected Devon Rex and 19 healthy Devon
Rex cats were genotyped on the Illumina Infinium feline
63K array. Case–control population substructure was
evaluated with identity by descent (IBD) and samples
clustering (multidimensional scaling) analyses using PLINK
(Purcell et al. 2007), as described previously (Gandolfi et al.
2012) (Fig. 1a). Two affected cats were full siblings, two
samples had an IBD value of ~0.3 and the remaining three
samples showed some relatedness (~0.2). The most signif-
icantly associated SNP ID C2:144738996 on cat chromo-
some C2, the homolog to human chromosome 3, was at
position C2:131,341,886 (Praw = 8.89e
7, Bonferroni cor-
rection = 0.04) of feline genome assembly 6.2 (Montague
et al. 2014) (Fig. 1b, c), which is ~463-Kb upstream of
COLQ. A common homozygous haplotype of almost 5 Mb
within all cases spanning from position C2:128 192 494–
131 992 072 contained 31 annotated genes (Fig. S1).
Figure 1 Multidimensional scaling and Manhattan plot of the myopathy genome-wide association study (GWAS). (a) Multidimensional scaling
illustrating the distribution in two dimensions of the cases and controls of the Devon Rex used in the GWAS. The GWAS genomic inflation (ʎ) was
1.68. Although the detected population substructure is attributable to the relatedness between individuals, all samples were kept in the analysis due
to the low number of available cases. Population stratification can confound a study, resulting in both false-positive and false-negative results. False
results can be corrected using Bonferroni adjustment for multiple comparison and permutation testing analyses (see below). (b) Manhattan plot
summarizing the case–control GWAS for myopathy cats. The most significantly associated SNPs were on cat chromosome C2 at positions
131 341 886 and 132 070 766; COLQ was located within the two highest SNP associations. (c) Bonferroni-corrected values of each SNP included in
the case–control study. Variant at position 131 341 886 on chromosome C2 remained significant after Bonferroni correction (0.04) (log10 1.4) and
almost attains genome-wide significance after 100 000 permutations (Pgenome value = 0.13).
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As part of the 99 Lives Cat Genome Sequencing Initiative
(www.felinegenetics.missouri.edu/99Lives), one Devon Rex
cat with myopathy (Case 1; Shelton et al. 2007)) was
whole-genome sequenced. Two bar-coded PCR-free libraries
(350 and 550 bp) were prepared using Illumina’s TruSeq
DNA PCR-Free sample preparation kit (#FC-121-3001),
pooled and sequenced on a HiSeq 2000 (Illumina), gener-
ating paired-end 100-base reads to a genome depth of 20X.
Reads were demultiplexed, trimmed with TRIMMOMATIC (Bol-
ger et al. 2014) and aligned to the Felis catus 6.2 genome
(http://www.ncbi.nlm.nih.gov/assembly/320798) with
BWA-MEM (Li & Durbin 2009). Duplicates were marked
with SAMBLASTER (Faust & Hall 2014), and variants were
called with PLATYPUS (Rimmer et al. 2014). Variant effects
were predicted with SNPEFF (Cingolani et al. 2012) based on
Ensembl gene model release 75 (Cunningham et al. 2015).
Candidate variants genome wide and in the region of
association and their depth of coverage were identified using
dynamic filters based on phenotype-specific allele frequen-
cies in the Variant Explorer tool on the MAVERIX ANALYTIC
PLATFORM (maverixbio.com) and viewed using the UCSC
Genome Browser (Rosenbloom et al. 2015).
Considering SNP effects and their impacts (Table S2),
only five moderate impact variants in three different genes
(TOPBP1, NPHP3 and COLQ) were detected within the
associated haplotype, unique to the affected sequenced cat
and wild type in a sequence database of 18 additional
healthy cats of different breeds. COLQ (C2:131 805 630–
131 863 452) represented the only candidate gene in the
region, and only one missense mutation (c.1190G>A at
position 131 809 279 of chromosome C2) was identified
within the gene coding region, suggesting the cat as a
model for CMS. The publicly available COLQ sequence
(www.ensembl.org) more likely has exon 1 annotated
incorrectly; using the human exon 1 sequence, the feline
sequence was retrieved using the NCBI ‘trace archive’ tool
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&
BLAST_SPEC=TraceArchive&PAGE_TYPE=BlastSearch&
PROG_DEFAULTS=on). The exon 1 sequence is included in
the latest version of the genome assembly (position on
chromosome C2: 131 863 337–131 863 442), and reads
from all cats were aligned to the reference genome by
MAVERIX. No additional mutations segregating with the
phenotype were detected in exon 1. In silico sequence
translation of feline wild-type COLQ generated from the
1368-bp coding sequence (CDS) predicted a length of 455
amino acids. The predicted alignment suggests 88.4%
identity to human COLQ (Fig. S2). To further correlate the
identified variant with disease, 627 cats were genotyped by
direct Sanger-based sequencing or an allele-specific assay,
as described previously (Bighignoli et al. 2007; Gandolfi
et al. 2012) (Table 1, Table S1, Table S3). Eighteen affected
cats were homozygous for the variant, including DNA
isolated from formalin-fixed paraffin-embedded samples of
the originally described affected Devon Rex cats (Malik et al.
1993), case 1 with inclusion bodies (Shelton et al. 2007)
and cases 1 and 2 (four cats) with the a-dystroglycan
deficiency (Martin et al. 2008). To estimate the variant
frequency in the Devon Rex and Sphynx breeds, 202 Devon
Rex and 217 Sphynx that were submitted for DNA typing of
coat colors (i.e. not associated with the disease study) were
genotyped. Eight Devon Rex and one Sphynx were
heterozygotes, and none were homozygous for the COLQ
variant, implying allele frequencies of ~ 2.0% for Devon Rex
and 0.2% for Sphynx, a breed that has allowable outcrosses
to Devon Rex (Gandolfi et al. 2010). The variant was absent
in 168 cats from 26 different breeds (Table S1). The disease
was first identified in the Devon Rex, and the higher allele
frequency suggests the variant originated in this breed.
COLQ encodes the collagenous tail of acetylcholinesterase,
the enzyme that terminates signal transduction at the
neuromuscular junction (Cartaud et al. 2004; Kimbell et al.
2004). COLQ has three domains: an N-terminal proline-rich
attachment domain (PRAD), a collagen central domain and
a C-terminal domain. The ColQ strand is attached to an
AChE tetramer by the PRAD domain, whereas the collagen
and C-terminal domains assemble the triple helix (Ohno et al.
2000). Moreover, the C-terminal domain anchors the
structure to the muscle cell membrane basal lamina (Kimbell
et al. 2004) that includes association with the a-dystrogly-
can complex (Rotundo et al. 2005; Sigoillot et al. 2010). This
association may explain reduced expression of a-dystrogly-
can observed in some cats (Martin et al. 2008) as a
downstream effect of COLQ variants.
Human patients with COLQ variants (OMIM 603034) are
generally severely disabled from an early age, with respira-
tory difficulties and progressive involvement of the axial
muscles leading to severe scoliosis and restrictive ventilatory
deficit (Engel et al. 2003a). This clinical presentation is
similar in cats, which show lordosis rather than scoliosis.
Cats generally succumb to the disease by food-related
asphyxiation or aspiration pneumonia referable to bulbar
Table 1 COLQ c.1190A>G genotypes in domestic cats breeds
Type1 Population No.
Wild type
(C/C)
Carrier
(C/T)
Affected
(T/T)
Biased Devon Rex 40 17 5 18
Unbiased Devon Rex 202 194 8 (1.8%) 0
Sphynx 217 216 1 (0.2%) 0
Other
breeds (26)
168 168 0 0
Subtotal 587 578 9 0
Total 627 595 14 18
1Type implies if the cat samples were ‘biased’ because of collection as
part of the disease study versus ‘unbiased’ because the laboratory
conducted a population screen of samples submitted for other genetic
tests (typically coat color). Biased-affected cats include the cats from all
three publications (Malik et al. 1993; Shelton et al. 2007; Martin et al.
2008). Four of five sampled cats from Malik et al. (1993) were
successfully genotyped from formalin-fixed paraffin-embedded muscle
specimens.
© 2015 The Authors. Animal Genetics published by John Wiley & Sons Ltd
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weakness (Malik et al. 1993; Shelton & Engvall 2005). As
more CMS cases are attributed to COLQ variants, the
heterogeneity of the disease has proven to be substantial.
The majority of COLQ variants associated with CMS are
frameshift or nonsense mutations that truncate the protein
distally to PRAD (Ohno et al. 2000; Engel et al. 2003a; Engel
& Sine 2005; Mihaylova et al. 2008). COLQ missense
variants in humans have been identified in all three domains
(Mihaylova et al. 2008; Engel et al. 2015). The cat variant
(c.1190G>A) is associated with a cysteine to tyrosine
substitution (p.Cys397Tyr) in the wild-type protein within
the C-terminal domain (submitted NCBI SNP identifier
1791785835). In humans, missense changes have been
noted at p.Cys386Ser, p.Arg410Gln and p.ARg410Pro,
including a similar but upstream variant at p.Cys417Tyr as
well as a nonsense variant at p.Gln371Xaa.
The wide phenotypic and genotypic spectrum of EP AChE
deficiency has led to the discovery of several patients with
an absence of classical clinical symptoms that complicate
diagnoses, including absence of a multiple compound
muscle action potential (CMAP) (Mihaylova et al. 2008).
Clinical findings were similarly variable in the cats of this
report. Four genotyped cats [two Devon Rex (Shelton et al.
2007) and two Sphynxes (Martin et al. 2008)], which all
were considered affected, underwent electrodiagnostic test-
ing, consisting of electromyography (EMG), motor and
sensory nerve conduction velocity testing and repetitive
nerve stimulation (RNS). EMG findings ranged from pro-
longed insertion to spontaneous activity (fibrillation poten-
tials, positive sharp waves and complex repetitive
discharges). Numerous complex repetitive discharges were
found in the laryngeal muscles of one Sphynx. Although
CMAP amplitudes were reduced in one cat, sensory nerve
conduction velocity values were normal in all cats. All cats
had a normal CMAP morphology, that is multiple CMAPs
following a single stimulus were not observed. RNS results
were variable: One Devon Rex and one Sphynx had no
significant decrement (i.e. <10%), another Devon Rex
showed a mild decremental response whereas the other
Sphynx decremented greatly (Fig. S3a). Edrophonium
administration had no effect (Fig. S3b).
Identification of the COLQ variant associated with this
feline CMS affords clinicians the opportunity of establishing
a diagnosis via genetic testing in these breeds. Furthermore,
owners and breeders can now easily identify carriers in the
population. An accurate diagnosis increases available
therapeutic options for affected cats, such as the use of
drugs such as ephedrine.
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Table S1 COLQ c.1190G>A genotypes in domestic cat
breeds
Table S2 WGS variants identified in 209 coverage of an
affected Devon Rex.
Table S3 PCR primers used for genotyping COLQ variant in
cats.
Figure S1 Haplotype comparison between cases and con-
trols in the region of association.
Figure S2 COLQ CDS and protein sequence. Presented are
the feline wild-type and mutated CDS and amino acid COLQ
sequences.
Figure S3 Decremental response to repetitive nerve stimu-
lation at 3 Hz in an affected Sphynx cat.
Video S1 Sphynx cats with COLQ variant for congenital
myasthenic syndrome (CMS). Affected cats present with
passive ventroflexion of the head and neck, head bobbing,
scapulae protrusion, megaesophagus, generalized muscle
weakness and fatigability (Malik et al. 1993). The video
represents the three Sphynx male siblings that demon-
strated a-dystroglycan deficiency - Case 1 (Martin et al.
2008). Each cat died of food-related asphyxiation or
aspiration;
Video S2 Devon Rex cat with COLQ variant for congenital
myasthenic syndrome (CMS). Affected cats present with
passive ventroflexion of the head and neck, head bobbing,
scapulae protrusion, megaesophagus, generalized muscle
weakness and fatigability (Malik et al. 1993). The video
represents the Devon Rex with milder disease and crys-
talline inclusion bodies in muscle biopsy specimens – Case 1
(Shelton et al. 2007). This cat was euthanized due to
complications of a fibrosarcoma.
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